Abstract
A prospective, randomized, placebo-controlled study by Yaal-Hahoshen et al. published in a recent issue of The Oncologist that concluded that the botanical mixture LCS101 prevented hematological complications in breast cancer patients undergoing anthracycline- and taxane-based chemotherapy is critically reviewed.